Search

Your search keyword '"Thomas Réjean"' showing total 10 results
Start Over Author "Thomas Réjean" Publisher lippincott williams & wilkins
10 results on '"Thomas Réjean"'

2. Impact of previous HIV resistance and virologic failures on virologic outcome following a switch to dolutegravir with 2 NRTIs among people living with HIV.

Author

Sangaré, Mohamed N'dongo, Jean-Guy Baril, de Pokomandy, Alexandra, Laprise, Claudie, Klein, Marina, Thomas, Réjean, Tremblay, Cécile, Roger, Michel, Pexos, Costa, Greenwald, Zoe, Machouf, Nima, Durand, Madeleine, Hardy, Isabelle, Dakouo, Mamadou, Laporte, Louise, Trottier, Helen, Baril, Jean-Guy, and Deshaies, Catherine

Published
2020
Full Text
View/download PDF

4. Upregulation of IL-32 Isoforms in Virologically Suppressed HIV-Infected Individuals: Potential Role in Persistent Inflammation and Transcription From Stable HIV-1 Reservoirs.

Author

Zaidan, Sarah M., Leyre, Louise, Bunet, Rémi, Larouche-Anctil, Etienne, Turcotte, Isabelle, Sylla, Mohamed, Chamberland, Annie, Chartrand-Lefebvre, Carl, Ancuta, Petronela, Routy, Jean-Pierre, Baril, Jean-Guy, Trottier, Benoit, MacPherson, Paul, Trottier, Sylvie, Harris, Marianne, Walmsley, Sharon, Conway, Brian, Wong, Alexander, Thomas, Réjean, and Kaplan, Robert C.

Published
2019
Full Text
View/download PDF

6. Recurrence of Human Papillomavirus External Genital Wart Infection Among High-Risk Adults in Montréal, Canada.

Author

Thomas, Réjean, Steben, Marc, Greenwald, Zoë, Stutz, Melissa, Rodier, Caroline, DeAngelis, Fern, and Rampakakis, Emmanouil

Subjects
*GENITAL warts treatment, *COLD therapy, *GENITAL warts, *HEALTH attitudes, *PAPILLOMAVIRUS diseases, *PAPILLOMAVIRUSES, *QUINOLINE, *CUTANEOUS therapeutics, *DISEASE relapse, *UNSAFE sex, *DISEASE prevalence, *RETROSPECTIVE studies, *THERAPEUTICS
Abstract

Objectives: The incidence of recurrent genital warts is not well characterized; this is especially true in a post-human papillomavirus (HPV) vaccination era. The objectives of this study were to assess the incidence of subsequent HPV-related external genital warts (EGW) episodes in high-risk male and female adults, as well as ascertain patient profile and disease characteristics, in a real-world Canadian sexual health clinical setting.Methods: Retrospective chart review study conducted at Clinique médicale l'Actuel, a sexual health clinic in Montréal, Québec, Canada. Eligible patients were 18 to 45 years of age with a first diagnosis of EGW associated with a HPV infection between July 1, 2006, and June 30, 2012.Results: A total of 400 first-episode EGW cases were identified. Up to 6 subsequent episodes were documented, with 194 (48.5%) patients reporting at least 1 subsequent EGW episode. Median time to first subsequent EGW episode was 3.97 years, and the incidence density rate for all subsequent episodes was 0.18/100 patient-years. Over 90% of patients reported clearance of the first subsequent episode, with median time to clearance of 0.30 years. Regardless of subsequent episode number, greater than 95% of patients received treatment, primarily cryotherapy, with high-risk sexual behavior reducing as number of episodes increased.Conclusions: Overall, a high rate of subsequent EGW episodes was observed in this high-risk population, despite high treatment rates and improvement in high-risk sexual behavior. These data, assessed in a prevaccination Québec health care system, may be compared with future EGW rates to assess the impact of a governmentally-funded HPV vaccination program. [ABSTRACT FROM AUTHOR]

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results